Retrobulbar injection of amphotericin B using intravenous cannula for post-COVID-19 rhino-orbital mucormycosis
Rhino-orbital mucormycosis has seen a huge resurgence in patients post COVID-19 infection. In patients with minimal orbital disease and especially with preserved vision, retrobulbar injections of amphotericin B can be of great help in controlling the disease. Instead of giving daily injections of am...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
| Series: | Indian Journal of Ophthalmology |
| Subjects: | |
| Online Access: | http://www.ijo.in/article.asp?issn=0301-4738;year=2022;volume=70;issue=1;spage=302;epage=305;aulast=Murthy |
| _version_ | 1798033654291628032 |
|---|---|
| author | Ramesh Murthy Aadhyaa Bagchi Yogita Gote Sanjay Desai |
| author_facet | Ramesh Murthy Aadhyaa Bagchi Yogita Gote Sanjay Desai |
| author_sort | Ramesh Murthy |
| collection | DOAJ |
| description | Rhino-orbital mucormycosis has seen a huge resurgence in patients post COVID-19 infection. In patients with minimal orbital disease and especially with preserved vision, retrobulbar injections of amphotericin B can be of great help in controlling the disease. Instead of giving daily injections of amphotericin B using needles every time, we used an 18-gauge intravenous (IV) cannula with injection port and suture holes to deliver the amphotericin into the orbital space for a period of 5 days. Patients were more compliant and less distressed with this method compared with being given an injection with a needle daily. We got a good response in terms of orbital disease regression with this method. In our review of the literature, we did not come across any such case of amphotericin B injection using an IV cannula. Injection of amphotericin B into the orbit using an IV cannula is a viable and easy treatment option for cases of rhino-orbital mucormycosis. |
| first_indexed | 2024-04-11T20:32:33Z |
| format | Article |
| id | doaj.art-9750f116f709455a8efad52638e40e97 |
| institution | Directory Open Access Journal |
| issn | 0301-4738 1998-3689 |
| language | English |
| last_indexed | 2024-04-11T20:32:33Z |
| publishDate | 2022-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Indian Journal of Ophthalmology |
| spelling | doaj.art-9750f116f709455a8efad52638e40e972022-12-22T04:04:27ZengWolters Kluwer Medknow PublicationsIndian Journal of Ophthalmology0301-47381998-36892022-01-0170130230510.4103/ijo.IJO_1511_21Retrobulbar injection of amphotericin B using intravenous cannula for post-COVID-19 rhino-orbital mucormycosisRamesh MurthyAadhyaa BagchiYogita GoteSanjay DesaiRhino-orbital mucormycosis has seen a huge resurgence in patients post COVID-19 infection. In patients with minimal orbital disease and especially with preserved vision, retrobulbar injections of amphotericin B can be of great help in controlling the disease. Instead of giving daily injections of amphotericin B using needles every time, we used an 18-gauge intravenous (IV) cannula with injection port and suture holes to deliver the amphotericin into the orbital space for a period of 5 days. Patients were more compliant and less distressed with this method compared with being given an injection with a needle daily. We got a good response in terms of orbital disease regression with this method. In our review of the literature, we did not come across any such case of amphotericin B injection using an IV cannula. Injection of amphotericin B into the orbit using an IV cannula is a viable and easy treatment option for cases of rhino-orbital mucormycosis.http://www.ijo.in/article.asp?issn=0301-4738;year=2022;volume=70;issue=1;spage=302;epage=305;aulast=Murthyamphotericin bintravenous cannularhino-orbital mucormycosis |
| spellingShingle | Ramesh Murthy Aadhyaa Bagchi Yogita Gote Sanjay Desai Retrobulbar injection of amphotericin B using intravenous cannula for post-COVID-19 rhino-orbital mucormycosis Indian Journal of Ophthalmology amphotericin b intravenous cannula rhino-orbital mucormycosis |
| title | Retrobulbar injection of amphotericin B using intravenous cannula for post-COVID-19 rhino-orbital mucormycosis |
| title_full | Retrobulbar injection of amphotericin B using intravenous cannula for post-COVID-19 rhino-orbital mucormycosis |
| title_fullStr | Retrobulbar injection of amphotericin B using intravenous cannula for post-COVID-19 rhino-orbital mucormycosis |
| title_full_unstemmed | Retrobulbar injection of amphotericin B using intravenous cannula for post-COVID-19 rhino-orbital mucormycosis |
| title_short | Retrobulbar injection of amphotericin B using intravenous cannula for post-COVID-19 rhino-orbital mucormycosis |
| title_sort | retrobulbar injection of amphotericin b using intravenous cannula for post covid 19 rhino orbital mucormycosis |
| topic | amphotericin b intravenous cannula rhino-orbital mucormycosis |
| url | http://www.ijo.in/article.asp?issn=0301-4738;year=2022;volume=70;issue=1;spage=302;epage=305;aulast=Murthy |
| work_keys_str_mv | AT rameshmurthy retrobulbarinjectionofamphotericinbusingintravenouscannulaforpostcovid19rhinoorbitalmucormycosis AT aadhyaabagchi retrobulbarinjectionofamphotericinbusingintravenouscannulaforpostcovid19rhinoorbitalmucormycosis AT yogitagote retrobulbarinjectionofamphotericinbusingintravenouscannulaforpostcovid19rhinoorbitalmucormycosis AT sanjaydesai retrobulbarinjectionofamphotericinbusingintravenouscannulaforpostcovid19rhinoorbitalmucormycosis |